Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 7.23
(-0.41%)
CNY 7.23
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.96 Billion | 6.56 Billion | 4.28 Billion | 2.76 Billion | 2.58 Billion | 1.8 Billion |
| Cost of Revenue | 4.73 Billion | 3.66 Billion | 2.06 Billion | 1.05 Billion | 926.63 Million | 600.1 Million |
| Gross Profit | 3.22 Billion | 2.89 Billion | 2.22 Billion | 1.71 Billion | 1.65 Billion | 1.2 Billion |
| Operating Expenses | 1 Billion | 861.36 Million | 726.97 Million | 625.04 Million | 718.48 Million | 634.19 Million |
| Selling, General and Administrative Expenses | 672.46 Million | 462.95 Million | 392.07 Million | 300.69 Million | 437.25 Million | 379.05 Million |
| Research and Development Expenses | 173.73 Million | 145.7 Million | 129.01 Million | 129.69 Million | 102.43 Million | 96.18 Million |
| Other Expenses | 157.46 Million | 252.7 Million | 205.87 Million | 194.65 Million | 178.79 Million | 158.94 Million |
| Cost and Expenses | 5.73 Billion | 4.52 Billion | 2.79 Billion | 1.67 Billion | 1.64 Billion | 1.23 Billion |
| Operating Income | 2.22 Billion | 2.27 Billion | 1.55 Billion | 1.5 Billion | 735.94 Million | 569.93 Million |
| Interest Expense | 457.87 Thousand | 263.18 Thousand | 472.08 Thousand | 376.15 Thousand | 1.69 Million | 66.02 Million |
| Income Tax Expense | 426.65 Million | 400.6 Million | 250.08 Million | 158.64 Million | 127.21 Million | -232.7 Million |
| Earnings before Tax | 2.2 Billion | 2.27 Billion | 1.53 Billion | 1.47 Billion | 733.14 Million | -1.75 Billion |
| Net Income | 1.77 Billion | 1.88 Billion | 1.29 Billion | 1.32 Billion | 607.89 Million | -1.52 Billion |
| Earnings Per Share Basic | 0.27 | 0.28 | 0.19 | 0.20 | 0.12 | -0.31 |
| Earnings Per Share Diluted | 0.27 | 0.28 | 0.19 | 0.20 | 0.12 | -0.31 |
| Weighted Average Shares Outstanding | 6.59 Billion | 6.74 Billion | 6.74 Billion | 6.74 Billion | 5.06 Billion | 4.89 Billion |
| Weighted Average Shares Outstanding (Diluted) | 6.59 Billion | 6.74 Billion | 6.74 Billion | 6.74 Billion | 5.06 Billion | 4.89 Billion |
| Gross Margin | 0.41 | 0.44 | 0.52 | 0.62 | 0.64 | 0.67 |
| EBIT Margin | 0.30 | 0.41 | 0.49 | 0.65 | 0.44 | -0.21 |
| Profit Margin | 0.22 | 0.29 | 0.30 | 0.48 | 0.24 | -0.84 |
| EBITDA | 2.36 Billion | 2.45 Billion | 1.3 Billion | 1.63 Billion | 885.13 Million | -1.51 Billion |
| Earnings Before Tax Margin | 0.28 | 0.35 | 0.36 | 0.54 | 0.28 | 0.32 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.06 Billion | 2.17 Billion | 2.04 Billion | 2.01 Billion | 7.92 Billion | 2.03 Billion |
| Cost of Revenue | 1.23 Billion | 1.3 Billion | 1.24 Billion | 1.27 Billion | 4.75 Billion | 1.2 Billion |
| Gross Profit | 827.58 Million | 877.12 Million | 802.5 Million | 741.93 Million | 3.17 Billion | 828.18 Million |
| Operating Expenses | 253.96 Million | 299.94 Million | 213.79 Million | 220.19 Million | 864 Million | 231.13 Million |
| Selling, General and Administrative Expenses | 389.42 Million | 233.06 Million | 164.92 Million | 165.52 Million | - | 300.48 Million |
| Research and Development Expenses | 84.75 Million | 54.62 Million | 50.08 Million | 39.97 Million | - | 45.58 Million |
| Other Expenses | -220.21 Million | -12.25 Million | 1.21 Million | -14.69 Million | -22.86 Million | -4.94 Million |
| Cost and Expenses | 1.48 Billion | 1.6 Billion | 1.45 Billion | 1.49 Billion | 5.61 Billion | 1.43 Billion |
| Operating Income | 712.43 Million | 577.18 Million | 588.7 Million | 521.74 Million | 2.31 Billion | 657.15 Million |
| Interest Expense | 15.6 Thousand | 24.2 Thousand | 21.58 Thousand | 35.21 Thousand | 119.75 Thousand | 23.8 Thousand |
| Income Tax Expense | 96.65 Million | 82.46 Million | 146.03 Million | 104.96 Million | 426.65 Million | 104.43 Million |
| Earnings before Tax | 694.1 Million | 495.8 Million | 813.33 Million | 549.18 Million | 2.36 Billion | 652.2 Million |
| Net Income | 597 Million | 483.98 Million | 756.81 Million | -8.12 Million | 1.77 Billion | 548.6 Million |
| Earnings Per Share Basic | 0.09 | 0.07 | 0.11 | -0.00 | - | 0.08 |
| Earnings Per Share Diluted | 0.09 | 0.07 | 0.11 | -0.00 | - | 0.08 |
| Weighted Average Shares Outstanding | 6.63 Billion | 6.6 Billion | 6.6 Billion | 6.6 Billion | 6.69 Billion | 6.69 Billion |
| Weighted Average Shares Outstanding (Diluted) | 6.63 Billion | 6.6 Billion | 6.6 Billion | 6.6 Billion | 6.69 Billion | 6.69 Billion |
| Gross Margin | 0.40 | 0.40 | 0.39 | 0.37 | 0.40 | 0.41 |
| EBIT Margin | 0.34 | 0.29 | 0.44 | 0.28 | - | 0.36 |
| Profit Margin | 0.29 | 0.22 | 0.37 | -0.00 | 0.22 | 0.27 |
| EBITDA | 694.11 Million | 635.7 Million | 905.72 Million | 564.23 Million | - | 724.1 Million |
| Earnings Before Tax Margin | 0.35 | 0.26 | 0.29 | 0.26 | 0.29 | 0.32 |
FRRPF
300690
066575
DPLS
011930
301021